189 related articles for article (PubMed ID: 37361590)
1. Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database.
Bi J; Lyu PF; Wang Y; Zhang H
Front Oncol; 2023; 13():1185650. PubMed ID: 37361590
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis.
Qian B; Hu L; Zhang S; Zhu J; Mei L; Huang T; Qu X
Front Endocrinol (Lausanne); 2022; 13():944758. PubMed ID: 35992148
[TBL] [Abstract][Full Text] [Related]
3. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
[No Abstract] [Full Text] [Related]
4. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
Zhao H; Gong Y
Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
[TBL] [Abstract][Full Text] [Related]
5. Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance.
Ding W; Ruan G; Lin Y; Zhu J; Li Z; Ye D
Front Endocrinol (Lausanne); 2023; 14():1235006. PubMed ID: 37745712
[TBL] [Abstract][Full Text] [Related]
6. Is lobectomy sufficient for multifocal papillary thyroid microcarcinoma?
Park KW; Han AY; Kim CM; Wang MB; Nguyen CT
Am J Otolaryngol; 2023; 44(4):103881. PubMed ID: 37031520
[TBL] [Abstract][Full Text] [Related]
7. Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: A propensity score matching analysis.
Yan T; Qiu W; Song J; Ying T; Fan Y; Yang Z
Clin Endocrinol (Oxf); 2021 Jul; 95(1):209-216. PubMed ID: 33660317
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.
Yan L; Zhang M; Song Q; Luo Y
Thyroid; 2021 Nov; 31(11):1662-1672. PubMed ID: 34269611
[No Abstract] [Full Text] [Related]
9. Prognosis of FTC compared to PTC and FVPTC: findings based on SEER database using propensity score matching analysis.
Liu Z; Zeng W; Huang L; Wang Z; Wang M; Zhou L; Chen D; Feng H; Zhou W; Guo L
Am J Cancer Res; 2018; 8(8):1440-1448. PubMed ID: 30210915
[TBL] [Abstract][Full Text] [Related]
10. The impact of surgery refusal on thyroid cancer survival: a SEER-based analysis.
van Gerwen M; Sinclair C; Rahman M; Genden E; Taioli E
Endocrine; 2020 Nov; 70(2):356-363. PubMed ID: 32307656
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study.
Yan L; Zhang M; Song Q; Xie F; Luo Y
Eur Radiol; 2022 Feb; 32(2):1216-1226. PubMed ID: 34357450
[TBL] [Abstract][Full Text] [Related]
12. Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching.
Liu Z; Zhao Q; Liu C; Zeng W; Ming J; Chen C; Wang S; Xiong Y; Zhang C; Chen T; Huang T; Guo L
Medicine (Baltimore); 2018 Aug; 97(31):e11791. PubMed ID: 30075609
[TBL] [Abstract][Full Text] [Related]
13. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
14. Columnar cell papillary thyroid carcinoma prognosis: findings from the SEER database using propensity score matching analysis.
Wang S; Xiong Y; Zhao Q; Song H; Yi P; Liu C
Am J Transl Res; 2019; 11(9):6262-6270. PubMed ID: 31632592
[TBL] [Abstract][Full Text] [Related]
15. Clinical Implication of Bilateral and Unilateral Multifocality in Papillary Thyroid Carcinoma: A Propensity Score-Matched Study.
Kim Y; An S; Park J; Bae JS; Kim JS; Kim K
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509259
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching.
Lee J; Park JH; Lee CR; Chung WY; Park CS
Thyroid; 2013 Nov; 23(11):1408-15. PubMed ID: 23509895
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonographical, clinical and histopathological features of 1264 nodules with papillary thyroid carcinoma and microcarcinoma based on tumor size.
Seyrek NC; Baser H; Topaloglu O; Ozdemir D; Kilicarslan A; Ersoy R; Cakir B
Arch Endocrinol Metab; 2021 May; 64(5):533-541. PubMed ID: 34033293
[TBL] [Abstract][Full Text] [Related]
18. Association of adjuvant radioactive iodine therapy with survival in node-positive papillary thyroid cancer.
Sun Y; Gong J; Guo B; Shang J; Cheng Y; Xu H
Oral Oncol; 2018 Dec; 87():152-157. PubMed ID: 30527231
[TBL] [Abstract][Full Text] [Related]
19. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of adjuvant external beam radiotherapy for papillary thyroid cancer based on competitive risk model and propensity score matching.
Zhou J; Wu C; Fan S; Zhao M
Sci Rep; 2023 Apr; 13(1):6925. PubMed ID: 37117278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
